Inherited variation in immune genes and pathways and glioblastoma risk
暂无分享,去创建一个
Susan M. Chang | M. Berger | M. Prados | S. Shete | R. Houlston | K. Muir | A. Swerdlow | M. Schoemaker | Ping Yang | M. Wrensch | M. Bondy | J. Wiencke | P. Decker | R. Jenkins | J. Schwartzbaum | Yuanyuan Xiao | T. Rice | L. McCoy | Joe Patoka | J. Wiemels | M. Kosel | P. McKinney | F. Hosking | S. Hepworth | Yanhong Liu | S. Tsavachidis | Jeffrey S. Chang | Lindsay B. Robertson | Bo Ding
[1] W. Willett,et al. A genome-wide association study identifies alleles in FGFR 2 associated with risk of sporadic postmenopausal breast cancer , 2012 .
[2] A. Auvinen,et al. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk , 2010, Acta oncologica.
[3] E. Chiocca,et al. Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma. , 2010, Neuro-oncology.
[4] K. Lange,et al. Prioritizing GWAS results: A review of statistical methods and recommendations for their application. , 2010, American journal of human genetics.
[5] Jason H. Moore,et al. BIOINFORMATICS REVIEW , 2005 .
[6] Scott M. Williams,et al. challenges for genome-wide association studies , 2010 .
[7] I. Kim,et al. Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCδ activation , 2010, Molecular Biology Reports.
[8] W. Tan,et al. Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib. , 2009, Lung cancer.
[9] C. Hawrylowicz,et al. Regulatory T cells in asthma. , 2009, Immunity.
[10] Igor Jurisica,et al. A comprehensive catalogue of functional genetic variations in the EGFR pathway: Protein–protein interaction analysis reveals novel genes and polymorphisms important for cancer research , 2009, International journal of cancer.
[11] D. Robinson. Regulatory T cells and asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[12] Melissa Bondy,et al. Genome-wide association study identifies five susceptibility loci for glioma , 2009, Nature Genetics.
[13] Alexander R. Pico,et al. Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility , 2009, Nature Genetics.
[14] Mary Helen Barcellos-Hoff,et al. Therapeutic targets in malignant glioblastoma microenvironment. , 2009, Seminars in radiation oncology.
[15] A. Kaye,et al. The EGFRvIII variant in glioblastoma multiforme , 2009, Journal of Clinical Neuroscience.
[16] N. Rothman,et al. Common Variation in Genes Related to Innate Immunity and Risk of Adult Glioma , 2009, Cancer Epidemiology Biomarkers & Prevention.
[17] R. Somasundaram,et al. Chemokines and the microenvironment in neuroectodermal tumor-host interaction. , 2009, Seminars in cancer biology.
[18] A. Olshan,et al. Reproductive factors and hormone use and risk of adult gliomas , 2009, Cancer Causes & Control.
[19] K. Aldape,et al. Polymorphisms in the Interleukin-4 Receptor Gene are Associated with Better Survival in Patients with Glioblastoma , 2008, Clinical Cancer Research.
[20] Nilanjan Chatterjee,et al. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. , 2008, Carcinogenesis.
[21] John Whittaker,et al. Analysis of multiple SNPs in a candidate gene or region , 2008, Genetic epidemiology.
[22] K. Aldape,et al. Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.
[23] W. Willett,et al. Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.
[24] N. Morton,et al. Mapping a gene for rheumatoid arthritis on chromosome 18q21 , 2007, BMC proceedings.
[25] N. Rothman,et al. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. , 2007, Carcinogenesis.
[26] M. Boehnke,et al. So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. , 2007, American journal of human genetics.
[27] A. Auvinen,et al. An International Case-Control Study of Interleukin-4Rα, Interleukin-13, and Cyclooxygenase-2 Polymorphisms and Glioblastoma Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.
[28] E. Linos,et al. Atopy and risk of brain tumors: a meta-analysis. , 2007, Journal of the National Cancer Institute.
[29] Jianfeng Xu,et al. Assembly of Inflammation-Related Genes for Pathway-Focused Genetic Analysis , 2007, PloS one.
[30] Sam Abolrous,et al. Learn C , 2007 .
[31] Naohito Yamaguchi,et al. The INTERPHONE study: design, epidemiological methods, and description of the study population , 2007, European Journal of Epidemiology.
[32] L. Boon,et al. CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo , 2007, International journal of cancer.
[33] M. Moghadassi,et al. Allergy-Related Polymorphisms Influence Glioma Status and Serum IgE Levels , 2007, Cancer Epidemiology Biomarkers & Prevention.
[34] W. Willett,et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.
[35] P. Fearnhead,et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.
[36] Tao Wang,et al. Improved power by use of a weighted score test for linkage disequilibrium mapping. , 2007, American journal of human genetics.
[37] H. Dressman,et al. Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers , 2006, Clinical Cancer Research.
[38] L. Chin,et al. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. , 2006, Cancer research.
[39] Y. Marie,et al. Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma , 2006, Neurology.
[40] Philip S Rosenberg,et al. Resampling‐based multiple hypothesis testing procedures for genetic case‐control association studies , 2006, Genetic epidemiology.
[41] M. Lesniak,et al. An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme. , 2006, Neuro-oncology.
[42] T. Giese,et al. In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. , 2006, Blood.
[43] K. Aldape,et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. , 2006, Cancer research.
[44] David E. Anderson,et al. Regulatory cells and human cancer. , 2006, Seminars in cancer biology.
[45] Clare Baecher-Allan,et al. Immune regulation in tumor-bearing hosts. , 2006, Current opinion in immunology.
[46] A. Friedman,et al. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. , 2006, Cancer research.
[47] C. Power,et al. Cohort profile: 1958 British birth cohort (National Child Development Study). , 2006, International journal of epidemiology.
[48] J. Blakely. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. , 2006, Cancer research.
[49] Shiang Huang,et al. Increased population of CD4+CD25high regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients , 2005, European journal of haematology.
[50] R. Lea,et al. Role of Cytokines in the Regulation of Glioma Tumour Growth and Angiogenesis , 2005 .
[51] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[52] M. Moghadassi,et al. Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme. , 2004, American journal of epidemiology.
[53] T. Speed,et al. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. , 2004, Bioinformatics.
[54] J. Berzofsky,et al. Immunoregulatory T cells in tumor immunity. , 2004, Current opinion in immunology.
[55] R. Ransohoff,et al. Analysis of leukocyte extravasation across the blood-brain barrier: Conceptual and technical aspects , 2004, Current allergy and asthma reports.
[56] Nathaniel Rothman,et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.
[57] Frank Dudbridge,et al. Rank truncated product of P‐values, with application to genomewide association scans , 2003, Genetic epidemiology.
[58] H. Fujii,et al. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[59] T. Sasada,et al. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies , 2003, Cancer.
[60] P. Hersey,et al. Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[61] M. Steurer,et al. Increase of regulatory T cells in the peripheral blood of cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[62] T. Eberlein,et al. Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1 , 2002, The Journal of Immunology.
[63] C. June,et al. Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1 , 2002, The Journal of Immunology.
[64] B S Weir,et al. Truncated product method for combining P‐values , 2002, Genetic epidemiology.
[65] F. Davis,et al. Epidemiology of brain tumors. , 2000, Current opinion in neurology.
[66] Philip H. Ramsey. Nonparametric Statistical Methods , 1974, Technometrics.
[67] S. S. Young,et al. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .